Document is current
Any future updates will be listed below
-
Authors
Turner, Jackson S.
Kim, Wooseob https://orcid.org/0000-0002-9199-1000
Kalaidina, Elizaveta
Goss, Charles W.
Rauseo, Adriana M.
Schmitz, Aaron J. https://orcid.org/0000-0002-8077-6751
Hansen, Lena
Haile, Alem
Klebert, Michael K.
Pusic, Iskra
O’Halloran, Jane A. https://orcid.org/0000-0001-8265-9471
Presti, Rachel M. https://orcid.org/0000-0002-5469-0727
Ellebedy, Ali H. https://orcid.org/0000-0002-6129-2532
- License Information
-
More Information
Article History
Received: 20 December 2020
Accepted: 14 May 2021
First Online: 24 May 2021
Competing interests
: The Ellebedy laboratory received funding under sponsored research agreements that are unrelated to the data presented in the current study from Emergent BioSolutions and from AbbVie. J.S.T., A.J.S. and A.H.E. are recipients of a licensing agreement with Abbvie that is unrelated to the data presented in the current study. A.H.E. is a consultant for Mubadala Investment Company and the founder of ImmuneBio Consulting. All other authors declare no competing interests.
Free to read: This content has been made available to all.
